Concepedia

Publication | Closed Access

Phase I clinical trial of recombinant human tumor necrosis factor in children with refractory solid tumors: a Pediatric Oncology Group study.

DOI

46

Citations

34

References

1993

Year

Wayne L. Furman, Douglas Strother, Kenneth L. McClain, Beverly Bell, B G Leventhal, C B Pratt
Journal of Clinical Oncology

Abstract

We recommend that phase II testing proceed at a dose of 300 micrograms/m2/d on the schedule described.

References

YearCitations

Page 1